From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA staff focus on safety of bladder drug

from Reuters

Drug reviewers said Astellas Pharma's treatment for an overactive bladder worked, but they raised concerns about liver and heart safety issues. The Food and Drug Administration staff said the once-daily tablet, called mirabegron, worked to reduce frequent urination and the inability to control it, according to documents. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063